Embecta Corp.
Health
Performance
8.5
Risk
Sell
Buy
Curious about the Scores? Learn more.

Embecta Corp. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

03.01.2026
Red alert. Risk levels out of control.
26.11.2025
Breaking down. The red game over screen is flashing.
25.11.2025
Momentum tanked. Clearly underperforming.
20.08.2025
Climbing out. Risks fading, but not out of the woods.

Embecta Corp. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Embecta Corp. do? Business model and key facts

Get the full picture of Embecta Corp.: what it builds, where it operates, and how it makes money.

Embecta Corp. Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 2000

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

shop
Company facts
Devdatt Kurdikar
CEO
2000
Employees worldwide
shop
Performance
-46.39%
Last 12 months
-77.87%
Last 5 years
shop
Growth
$1,08B
Revenue year
$95,40M
Net income
shop
Valuation
$615,80M
Market Cap
8.62
Price/Earnings Ratio

Stocks related to Embecta Corp.

Selected based on industry alignment and relative market positioning.

PCRX
Pacira BioSciences, Inc.
19.85
-3.17%
5.9
Sell
Buy
Pacira BioSciences, Inc.
CRON
Cronos Group Inc.
2.71
+0.74%
5.3
Sell
Buy
Cronos Group Inc.
AMPH
Amphastar Pharmaceuticals, Inc.
26.25
-1.32%
6.3
Sell
Buy
Amphastar Pharmaceuticals, Inc.
GUD.TO
Knight Therapeutics Inc.
5.77
-1.20%
2.3
Sell
Buy
Knight Therapeutics Inc.
KMDA
Kamada Ltd.
8.87
+3.62%
2.9
Sell
Buy
Kamada Ltd.

Embecta Corp. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.